Colgate-Palmolive (CL) Q1 2025 10-Q Quarterly Report

Filed: Apr 25, 2025Period ending Mar 31, 2025

Health Care

Perfumes, Cosmetics & Other Toilet PreparationsSEC EDGAR

Colgate-Palmolive (CL) 10-Q quarterly report for Q1 2025, filed with SEC EDGAR on Apr 25, 2025 for the fiscal period ending Mar 31, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

Colgate-Palmolive Q1 2025 10-Q Analysis

Risk Factors

• New risk: ERISA litigation charges in Q1 2025 increased non-service postretirement costs by $50M, impacting operating profit and SG&A expenses
• Updated operational risk: Raw and packaging material cost inflation up to 570 bps in Latin America severely pressure Gross profit margins
• Regulatory risk: Ongoing IRS audits for tax years 2010-2018 and 2019-2021 with potential $153M exposure, despite company contesting assessments
• Market risk: Organic sales decline of 3.0% in North America driven by volume decline in personal and home care categories, hurting near-term revenue
• Financial risk: Total debt rose to $8,269M as of March 31, 2025, partly financing Care TopCo pet food acquisition closing Q2 2025

Colgate-Palmolive Q1 2025 Quarterly Financials
XBRL

Revenue

$4.9B

▼ -3.0% YoY

Net Income

$690M

▲ +1.0% YoY

Gross Margin

60.8%

▲ +82bp YoY

Operating Margin

21.9%

▲ +124bp YoY

Net Margin

14.1%

▲ +57bp YoY

EPS (Diluted)

$0.85

▲ +2.4% YoY

Operating Cash Flow

$600M

▼ -11.9% YoY

Source: XBRL data from Colgate-Palmolive Q1 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other Colgate-Palmolive Quarterly Reports

Q3 2025 10-Q

Get deeper insights on Colgate-Palmolive

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.